Literature DB >> 6806545

Effects of cardioplegic solutions on conductive coronary arteries.

M Chiavarelli, M Toscano, R Chiavarelli, A Carpi, B Marino.   

Abstract

The effects of two cardioplegic solutions (CPSs) on isolated, superfused, bovine coronary arteries were compared with those produced by changes in composition of standard Krebs medium. High potassium, low sodium content or the addition of albumin produced vasoconstriction; high magnesium, high glucose content or the addition of mannitol led to vasodilatation. In most cases hypothermia slightly reduced vasoconstriction and enhanced vasodilatation. The action of the two CPSs is the result of the interaction of these basic effects. The results suggest that the vasomotor reactions of coronary arteries to CPS may affect the delivery of the CPS to the myocardium and exert a critical influence on successful cardioplegia.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6806545

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  4 in total

1.  Myocardial protection utilizing calcium containing and calcium free perfusates.

Authors:  O H Bing; P J LaRaia; A Franklin; J Stoughton; J A Hayman; R M Weintraub
Journal:  Basic Res Cardiol       Date:  1985 Jul-Aug       Impact factor: 17.165

2.  Blood cardioplegia delivery. Deleterious effects of potassium versus lidocaine.

Authors:  F G Leicher; P Magrassi; P J LaRaia; W M Derkac; M J Buckley; W G Austen
Journal:  Ann Surg       Date:  1983-09       Impact factor: 12.969

3.  Adenosine and lidocaine (AL) combination dilates intimally damaged rat thoracic aortic rings and guinea pig mesenteric arteries: possible significance to cardiac surgery.

Authors:  Aryadi Arsyad; Elke Sokoya; Geoffrey P Dobson
Journal:  Am J Transl Res       Date:  2018-06-15       Impact factor: 4.060

Review 4.  Hyperkalemic cardioplegia for adult and pediatric surgery: end of an era?

Authors:  Geoffrey P Dobson; Giuseppe Faggian; Francesco Onorati; Jakob Vinten-Johansen
Journal:  Front Physiol       Date:  2013-08-28       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.